Clinical Drug Investigation

Aims & Scope

Clinical Drug Investigation provides rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs.

The Journal includes: -Clinical trials, outcomes research, clinical pharmacoeconomic studies and pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs. -Clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice. -Pharmacodynamic and pharmacokinetic studies in healthy volunteers in which significant implications for clinical prescribing are discussed. -Studies focusing on the application of drug delivery technology in healthcare. -Short communications and case study reports that meet the above criteria will also be considered.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content.

In addition, articles published in Clinical Drug Investigation may be accompanied by plain language summaries to assist readers who have some knowledge, but non in-depth expertise in, the area to understand important medical advances.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.7
2024	2.90

Journal Rank

Year	Value
2024	7124

Journal Citation Indicator

Year	Value
2024	788

SJR (SCImago Journal Rank)

Year	Value
2024	0.771

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	70

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The Safety of Melatonin in Humans

  Citation: 370

  Authors: Lars Peter Holst, Ismail, Jacob, Russel J.

• Pharmacology of Silymarin

  Citation: 250

  Authors: F., G., D.

• Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review

  Citation: 236

  Authors: Domenico, Tatiana

• Impact of Adherence to Interferons in the Treatment of Multiple Sclerosis

  Citation: 205

  Authors: Stephanie C., Richard J., Cyril F., Andrew, Mark A.

• Pharmacokinetic Profile of Liposome Bupivacaine Injection Following a Single Administration at the Surgical Site

  Citation: 192

  Authors: DeeDee, Erol, Neil, William G., Admir

• HairMax LaserComb® Laser Phototherapy Device in the Treatment of Male Androgenetic Alopecia

  Citation: 185

  Authors: Matt, Glenn, Eugene, David

• Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee

  Citation: 171

  Authors: Marc, Mila S., Brigitte, Kathy, Akiko, Ilse, Achim, Bernd, Christine, Juergen

• Preliminary, Open-Label, Pilot Study of Add-On Oral Δ9-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder

  Citation: 166

  Authors: Pablo, Raphael, Rena, Arieh

• Adverse Effects Associated with Non-opioid and Opioid Treatment in Patients with Chronic Pain

  Citation: 154

  Authors: Roberto, Piercarlo, Stefano Maria, Paolo, Renato, Diego

• Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia

  Citation: 145

  Authors: Shengyu, Lei, Aizong, Yongwu, Zhigang

---